{"cik":1856653,"taxonomy":"us-gaap","tag":"LiabilitiesCurrent","label":"Liabilities, Current","description":"Total obligations incurred as part of normal operations that are expected to be paid during the following twelve months or within one business cycle, if longer.","entityName":"BioPlus Acquisition Corp.","units":{"USD":[{"end":"2021-12-31","val":179136,"accn":"0001193125-22-073378","fy":2021,"fp":"FY","form":"10-K","filed":"2022-03-11"},{"end":"2021-12-31","val":179136,"accn":"0001193125-22-148786","fy":2022,"fp":"Q1","form":"10-Q","filed":"2022-05-12"},{"end":"2021-12-31","val":179136,"accn":"0001193125-22-217405","fy":2022,"fp":"Q2","form":"10-Q","filed":"2022-08-10"},{"end":"2021-12-31","val":179136,"accn":"0001193125-22-277012","fy":2022,"fp":"Q3","form":"10-Q","filed":"2022-11-03"},{"end":"2021-12-31","val":179136,"accn":"0001193125-23-087738","fy":2022,"fp":"FY","form":"10-K","filed":"2023-03-31","frame":"CY2021Q4I"},{"end":"2022-03-31","val":239716,"accn":"0001193125-22-148786","fy":2022,"fp":"Q1","form":"10-Q","filed":"2022-05-12","frame":"CY2022Q1I"},{"end":"2022-06-30","val":241531,"accn":"0001193125-22-217405","fy":2022,"fp":"Q2","form":"10-Q","filed":"2022-08-10","frame":"CY2022Q2I"},{"end":"2022-09-30","val":288453,"accn":"0001193125-22-277012","fy":2022,"fp":"Q3","form":"10-Q","filed":"2022-11-03","frame":"CY2022Q3I"},{"end":"2022-12-31","val":526875,"accn":"0001193125-23-087738","fy":2022,"fp":"FY","form":"10-K","filed":"2023-03-31"},{"end":"2022-12-31","val":526875,"accn":"0001193125-23-145016","fy":2023,"fp":"Q1","form":"10-Q","filed":"2023-05-15"},{"end":"2022-12-31","val":526875,"accn":"0001193125-23-212329","fy":2023,"fp":"Q2","form":"10-Q","filed":"2023-08-14","frame":"CY2022Q4I"},{"end":"2023-03-31","val":700530,"accn":"0001193125-23-145016","fy":2023,"fp":"Q1","form":"10-Q","filed":"2023-05-15","frame":"CY2023Q1I"},{"end":"2023-06-30","val":1979217,"accn":"0001193125-23-212329","fy":2023,"fp":"Q2","form":"10-Q","filed":"2023-08-14","frame":"CY2023Q2I"}]}}